Skip to main content
SpringerLink
Log in
Book cover

Herzkrankheiten pp 1365–1383Cite as

ACE-Hemmer

  • Chapter

  • 65 Accesses

Zusammenfassung

Die Entwicklung von Hemmstoffen des Angiotensin-I-Konversionsenzyms (ACE/Kininase II) und ihre Einführung in Klinik und Praxis stellen einen Meilenstein in der Ermittlung neuer therapeutischer Wirkprinzipien während der letzten Jahre medizinischer Forschung dar. Dabei ist die Entdeckung dieser Substanzklasse untrennbar verknüpft mit der Erforschung des Renin-Angiotensin-Aldosteron-Systems (RAAS). Tabelle 54.1 zeigt hierzu die wichtigsten historischen Eckdaten.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Admiraal PJ, Derkx FHM, Danser AHJ et al (1990) Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15:44

    PubMed  CAS  Google Scholar 

  • Allgeier J, Goetz R, Busath R et al (1991) Chronische druckpassive Dehnung erhöht die vaskuläre ACE-Aktivität bei renaler Hypertonie in Ratten. Z Kardiol 80 (Suppl):67

    Google Scholar 

  • Amman FW, Buhler FR, Conen D et al (1980) Captopril-associated agranulocytosis. Lancet I:150

    Google Scholar 

  • Antanaccio MJ, Wright JJ (1990) Reninangiotensin-system, Converting enzyme and renin inhibitors. In: Antanaccio MJ (eds) Cardiovascular pharmacology. Raven Press, New York, p 201 ff

    Google Scholar 

  • Baker KM, Aceto JF (1990) Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259:610

    Google Scholar 

  • Baker KM, Chemin MI, Wixson SK, Aceto JF (1990) Renin-angiotensin-system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 259:H324

    PubMed  CAS  Google Scholar 

  • Berk BC, Vekshtein V, Gordon HM et al (1989) Angiotensin-II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305

    PubMed  CAS  Google Scholar 

  • Bhoola KD, Figuera CD, Worthy K (1992) Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacological Reviews 44/1:1

    PubMed  CAS  Google Scholar 

  • Bönner G, Schölkens BA, Scicli AG (1991) In: Bönner G, Schölkens BA (eds) The role of bradykinin in the cardiovascular action of the converting enzyme inhibitor ramipril. Scicli AG, Media Medica

    Google Scholar 

  • Boutroy MJ, Vert P, Hurault de Ligny B, Milton A (1984) Captopril administration in pregnancy impaired fetal angiotensin converting enzyme activity and neonatal adaptation. Lancet II.935

    Article  Google Scholar 

  • Bumpus FM, Catt KJ, Chiu AT et al (1991) Nomenclature for angiotensin receptors: A report of the nomenclature committee of the Council of High Blood Pressure Research. Hypertension 17:720

    PubMed  CAS  Google Scholar 

  • Campbell DJ (1985) Circulating and tissue angiotensin systems. J Clin Invest 79:1

    Article  Google Scholar 

  • Campbell DL (1987) The site of angiotensin production. J Hy-pertens 3:199

    Google Scholar 

  • Carini DJ, Duncia JV (1988) Angiotensin II blocking imidazoles. European patent application 0253310

    Google Scholar 

  • Coulter DM, Edwards IR (1987) Cough associated with Captopril and enalapril. Br Med J 294:1521

    Article  CAS  Google Scholar 

  • Cushman DW, Cheung HS, Sabo EF, Ondetti MA (1977) Design of competitive inhibitors of angiotensin-converting enzyme. Carboxyalkyl and mercaptoalkanoyl amino acids. Biochemistry 16:5484

    Article  PubMed  CAS  Google Scholar 

  • Dahlöf B, Pennert K, Hanson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. Am Metaanalysis of 109 treatment studies. Am J Hypertension 9:95

    Google Scholar 

  • De Jong PE, De Zeeuw D (1991) Renale Wirkungen der Konversionsenzymhemmer. Dtsch med Wschr 116:743

    Article  PubMed  Google Scholar 

  • Dickstein K, Chang P, Willenheimer R et al (1995) Comparison of the effects of losartan in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 26:438

    Article  PubMed  CAS  Google Scholar 

  • Drexler H, Hayez D, Münzel T et al (1991) Endothelial function in chronic heart failure. Am J Cardiol 69:1596

    Article  Google Scholar 

  • Drexler H, Lindpaintner K, Lu W et al (1989) Transient increase in the expression of cardiac angiotensinogen in a rat model of myocardial infarction and failure. Circulation 80 (Suppl 2):459

    Google Scholar 

  • Dubey RK, Ray A, Overbeck HW (1992) Culture of renal arteriolar smooth muscle cells: Mitogenic responses to angiotensin II. Circ Res 71:1143

    PubMed  CAS  Google Scholar 

  • Duncia JV, Carini DJ, Chiu, AT et al (1992) The discovery of DUP 753, a potent, orally active non-peptide angiotensin II receptor antagonist. Med Res Rev 12:149

    Article  PubMed  CAS  Google Scholar 

  • Dzau VJ (1984) Vascular renin-angiotensin: a possible autocrin or paracrine system in control of vascular function. J Car-diovasc Pharmacol 6:2377

    Google Scholar 

  • Dzau VJ (1986) Significance of the vascular renin angiotensin pathway. Hypertension 8:553

    PubMed  CAS  Google Scholar 

  • Dzau VJ (1987) Vascular angiotensin pathways: a new therapeutic target. J Cardiovasc Pharmacol 10 (Suppl 7):9

    Article  Google Scholar 

  • Dzau VJ (1988a) Tissue renin-angiotensin systems: physiologic and pharmacologic implications. Circulation 77 (Suppl 1):1

    Article  Google Scholar 

  • Dzau VJ (1988b) Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77 (Suppl 1):4

    Google Scholar 

  • Dzau VJ (1989) Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertension 7:933

    Article  CAS  Google Scholar 

  • Dzau VJ (1993) Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Bas Res Cardiol 88 (Suppl 1):1

    CAS  Google Scholar 

  • Dzau VJ, Hermann HC (1982) Hormonal control of angiotensinogen production. Life Sciences 30:577

    Article  PubMed  CAS  Google Scholar 

  • Dzau VJ, Pratt RE (1992) Renin angiotensin system. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE (eds) The heart and cardiovascular system. Raven Press, New York, p 1817

    Google Scholar 

  • Edwards CRW, Padfield PL (1985) Angiotensin-converting enzyme inhibitors: Past, present, and bright future. Lancet I:30

    Article  Google Scholar 

  • Erdös EG (1975) Angiotensin I converting enzyme. Circ Res 36:247

    PubMed  Google Scholar 

  • Erdös EG (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16:363

    PubMed  Google Scholar 

  • Ferreira SH (1985) History of the development of inhibitors of angiotensin I conversion. Drugs 30 (Suppl 7):1

    Article  PubMed  Google Scholar 

  • Ferreira SH, Bartelt DC, Greene JL (1970) Isolation of bradyki-nin-potentiating peptides from bothrops jararaca venom. Biochemistry 9:2583

    Article  PubMed  CAS  Google Scholar 

  • Finckh M, Hellmann W, Ganten D et al (1991) Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats. Bas Res Cardiol 86:303

    Article  CAS  Google Scholar 

  • Foult JM, Tavdaro O, Antony I et al (1988) Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation 77:337

    Article  PubMed  CAS  Google Scholar 

  • Gavras H, Brunner HR, Laragh JH et al (1974) An Angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. New Engl J Med 291:817

    Article  PubMed  CAS  Google Scholar 

  • Geisterfer AAT, Peach MJ, Owens GK (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749

    PubMed  CAS  Google Scholar 

  • Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on experimental hypertension I: The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347

    Article  PubMed  CAS  Google Scholar 

  • Gomez HJ, Cirillo VJ, Irvin JD (1985) Enalapril: a review of human pharmacology. Drugs 30 (Suppl 1):13

    Article  PubMed  Google Scholar 

  • Granger JP, Hall JE (1985) Acute and chronic actions of bradykinin on renal function and arterial pressure. Am J Physiol 248:F87

    PubMed  CAS  Google Scholar 

  • Gross F (1958) Renin and Hypertensin, physiologische und pat-hophysiologische Wirkstoffe. Klin Wochenschr 36:693

    Article  PubMed  CAS  Google Scholar 

  • Hackenthal E, Aktories K, Jakobs KH (1985) Mode of inhibition of renin release by angiotensin II. J Hypertension (Suppl 3):263

    Google Scholar 

  • Hall JE, Brands MW (1992) The renin-angiotensin-aldosteron systems: renal mechanisms and circulatory homeostasis. In: Sedin DW, Giebisch G (eds) The kidney: Physiology and Pathophysiology. Raven Press, New York

    Google Scholar 

  • Hodsman GP, Isles CG, Muray GD et al (1983) Factors related to first dose hypotensive effect of Captopril: prediction and treatment. Br Med J 286:832

    Article  CAS  Google Scholar 

  • Hood S, Nicholls MG, Gilchrist NL (1987) Cough with angiotensin converting enzyme inhibitors. N Z Med J 100:6

    PubMed  CAS  Google Scholar 

  • Hsuek WA, Baxter JD (1991) Human Prorenin. Hypertension 17:469

    Google Scholar 

  • Huih K, Duchin KL, Kripalani KJ et al (1991) Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Therap 49:457

    Article  Google Scholar 

  • Iwai N, Inagama T (1992) Identification of two subtypes in the rat type-1 angiotensin II receptor. FEBS Lett 298:257

    Article  PubMed  CAS  Google Scholar 

  • Jauch KW, Hartl W, Georgieff M et al (1988) Low-dose bradykinin infusion reduces endogenous glucose-production in surgical patients. Metabolism 37:185

    Article  PubMed  CAS  Google Scholar 

  • Jenne DE, Tschopp J (1991) Angiotensin-II-forming heart chy-mase in a mast-cell specific enzyme. Biochem J 276: 567

    PubMed  CAS  Google Scholar 

  • Katoh Y, Komuro J, Shibasaki Y et al (1989) Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes. Circulation 80 (Suppl 2):450

    Google Scholar 

  • Keane WF et al (1989) Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 111:503

    PubMed  CAS  Google Scholar 

  • Klett C, Hackenthal E (1987) Induction of angiotensinogen synthesis and secretion by angiotensin II. Clin Exp Hypert A9 12:2027

    Article  CAS  Google Scholar 

  • Kubo SH, Rector TS, Bank AJ et al (1991) Endothelium dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589

    PubMed  CAS  Google Scholar 

  • Landau C, Jacobs AK, Haudenshild CC (1992) Left ventricular hypertrophy induced by angiotensin II is accompanied by a dose-dependent fibrotic response. Circulation 86:1

    Google Scholar 

  • Lewis EJ, Hunsicker LG, Brain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456

    Article  PubMed  CAS  Google Scholar 

  • Lindpaintner K, Jin M, Wilhelm MJ et al (1988) Inracardiac generation of angiotensin and its physiologic role. Circulation 77 (Suppl 1):18

    Google Scholar 

  • Lindpaintner K, Wilhelm MJ, Jin M et al (1987) The tissue renin-angiotensin systems: focus on the heart. J Hypertens 5 (Suppl 2)5:33

    Article  Google Scholar 

  • Lüscher TF (1988) Endothelial vasoactive substances and cardiovascular desease. Karger, Basel

    Google Scholar 

  • Lynch KR, Peach MJ (1991) Molecular biology of angiotensino-gen. Hypertension 17:263

    PubMed  CAS  Google Scholar 

  • Mann J (1993) Pharmakokinetic von Konversionsenzym-Hem-mern. In: Bönner G, Rahn KH (eds) ACE-Hemmer-Hand-buch. Schattauer, New York, S 177

    Google Scholar 

  • MERCATOR Study Group (1992) Does the new angiotensin converting enzyme inhibitor Cilazapril prevent restenosis after percutaneous transluminal angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 86:100

    Google Scholar 

  • Murphy TJ, Alexander RW, Griendling KK et al (1991) Isolation of a cDNA encoding the vascular type-1-angiotensin II receptor. Nature 351:233

    Article  PubMed  CAS  Google Scholar 

  • Nakaki T, Nakayama M, Kato R (1990) Inhibition by nitric oxide and nitric-oxide producing vasodilators of DNA-synthe-sis in vascular smooth muscle cells. Eur J Pharmacol 189: 347

    Article  PubMed  CAS  Google Scholar 

  • Needlemann P, Key SL, Denny SE et al (1975) The mechanism and modification of bradykinin-induced coronary vasodilation. Proc Natl Acad USA 72:2060

    Article  Google Scholar 

  • Neyses et al (1989) Angiotensin II induces expression of the early growth response gene-1 in isolated adult cardiomyocytes. Circulation 80 (Suppl 2):450

    Google Scholar 

  • Okamura T, Miyazaki M, Inagami T et al (1986) Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 8:560

    PubMed  CAS  Google Scholar 

  • Ondetti MA, Cushman DW (1984) Angiotensin-converting-enzyme inhibitors: biochemical properties and biological actions. Crit Rev Biochem 16:381

    Article  CAS  Google Scholar 

  • Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196:441

    Article  PubMed  CAS  Google Scholar 

  • Ondetti MA, Williams NJ, Salvo EF et al (1971) Angiotensin-converting-inhibitors from the venom of bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10:4033

    Article  PubMed  CAS  Google Scholar 

  • Ontkean M, Gay R, Greenberg B (1992) Effect of chronic Captopril therapy on endothelium-derived relaxing factor activity in heart afailure. J Am Coll Cardiol 19:207 A

    Google Scholar 

  • Packer M (1988) Interaction of prostaglandins and angtiotensin II in the modulation of renal function in congestive heart failure. Circulation 77 (Suppl I) 1

    Google Scholar 

  • Paquet JL, Baudouin-legros M, Brunelle G et al (1990) Angiotensin II induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 8:565

    Article  PubMed  CAS  Google Scholar 

  • Patchett AA, Harris E, Tristan EW et al (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288: 280

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer JM, Pfeffer MA, Fletcher PJ et al (1991) Progressive ventricular remodelling in the rat with myocardial infarction. Am J Physiol 260:H1406

    PubMed  CAS  Google Scholar 

  • Plouin PF, Tchobroutsky C (1985) Inhibition of angiotensin converting enzyme in human pregnancy. Presse Med 14:2175

    PubMed  CAS  Google Scholar 

  • Powell JS, Clozel JP, Muller RKM et al (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186

    Article  PubMed  CAS  Google Scholar 

  • Santos RAS, Brosnihan KB, Jacobsen DW et al (1992) Production of angiotensin-(1,7) by human vascular endothelium. Hypertension 19 (Suppl II):56

    Google Scholar 

  • Sasaki K, Yamano Y, Bardhan S et al (1991) Cloning and expression of complementary DNA encoding a bovine adrenal angiotensin II type-1-receptor. Nature 351:230

    Article  PubMed  CAS  Google Scholar 

  • Sasamura H, Hain L, Krieger JE et al (1992) Molecular evidence for two angiotensin (AT-l)-receptor isoforms: tissue distribution and functional implications. Hypertension 20:416

    Google Scholar 

  • Schnerman J, Briggs JP (1992) Function of the juxtaglomerular apparatus: control of glomerular hemodynamic and renin secretion. In: Sedin DW, Giebisch G (eds) The kidney: Physiology and Pathophysiology. Raven Press, New York, S 1249

    Google Scholar 

  • Schölkens BA, Linz W, König W (1988) Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischemic rat heart are abolished by an bradykinin inhibitor. J Hypertens 6:525

    Article  Google Scholar 

  • Schölkens BA, Linz W, Lindpaintner K (1987) Angiotensin deteriorates but bradykinin improves cardiac function following ischemia in isolated rat hearts. J Hypertens 5 (Suppl 5):7

    Google Scholar 

  • Schunkert H, Dzau VJ, Tang SS et al (1991) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 86:1913

    Article  Google Scholar 

  • Schwartz SM, Heimark RL, Majewsky MW (1990) Developmental mechanisms underlying pathology or arteries. Physiol Rev 70:1177

    PubMed  CAS  Google Scholar 

  • Sernia C, Clements JA, Funder JW (1989) Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxin. Mol Cell Endocrin 61:147

    Article  CAS  Google Scholar 

  • Skeggs LT, Kahn JR, Shumway NP (1956) The preparation and function of the hypertensin converting enzyme. J Exp Med 103:295

    Article  PubMed  CAS  Google Scholar 

  • Skeggs LT, Lenz KE, Hochstrasser H et al (1963) The purification and partial characterization of several forms of dog renin substrate. J Exp Med 118:73

    Article  PubMed  CAS  Google Scholar 

  • Slater EE, Merill DD, Guess HA et al (1988) Clinical profile of angiooedema associated with angiotensin converting enzyme inhibition. J Am Med Ass 260:967

    Article  CAS  Google Scholar 

  • Stewart JM, Vavrek RJ (1986) Bradykinin competitive antagonists for classical kinin-systems. In: Greenbaum LM, Mar-golius JS (eds) Kinins IV. Plenum Press, New York, S 537

    Google Scholar 

  • Studer A, Vetter W (1982) Reversible leukopenia associated with angiotensin converting enzyme inhibitor M 421. Lancet I:458

    Article  Google Scholar 

  • Taugner R, Hackenthal E (1988) The juxtaglomerular apparatus. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Thurau K, Schnerman J, Nagel W et al (1967) Composition of tubular fluid in the macula densa segment as a factor regulating the function of the juxtaglomerular apperatus. Circ Res 20/21 (Suppl 2):79

    Google Scholar 

  • Tigerstedt R, Bergman PG (1898) Niere und Kreislauf. Skand Arch Physiol 8:223

    Google Scholar 

  • Timmermanns PB, Benfield P, Chiu AT et al (1992) Angiotensin II receptors and functional correlates. Am J Hypertens 5:2215

    Google Scholar 

  • Timmermanns PB, Wong PC, Chiu AT et al (1993) Angiotensin II receptors and angiotensin II receptor-antagonists. Pharmacol Rev 45:205

    Google Scholar 

  • Uhl D (1990) Mortalität bei Herzinsuffizienz. Studien zur Reduktion der Mortalität bei Herzinsuffizienz. Arzneimitteltherapie 8:174

    Google Scholar 

  • Unger T (1993) In: Bönner G, Rahn KH (Hrsg) ACE-Hem-mer-Handbuch. Schattauer, New York, S 75–76

    Google Scholar 

  • Unger TH, Schüll B, Rascher W et al (1982) Selective activation of the converting enzyme inhibitor MK-421 and comparison of its active diacid form with Captopril in different tissues of the rat. Biochem Pharmacol 19:3063

    Article  Google Scholar 

  • Urata H, Healy B, Stewart RW et al (1990) Angiotensin II forming pathways in normal and failing human hearts. Circ Res 66:883

    PubMed  CAS  Google Scholar 

  • Wang PH, Do YS, Macoulay L et al (1991) Identification of renal cathepsin B as human prorenin processing enzyme. J Biol Chem 266:12633

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Allgeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. F. Hauf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Allgeier, J., Hauf, G.F. (1996). ACE-Hemmer. In: Herzkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97605-6_54

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97605-6_54

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97606-3

  • Online ISBN: 978-3-642-97605-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation